Estrella Immunopharma, Inc. Common Stock (ESLA) is a publicly traded Healthcare sector company. As of September 8, 2026, ESLA trades at $0.64 with a market cap of $28.11M and a P/E ratio of -1.99. ESLA moved -4.07% today. Year to date, ESLA is -58.96%; over the trailing twelve months it is -35.97%. Its 52-week range spans $0.59 to $3.15. Rallies surfaces ESLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ESLA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.64 |
| Market Cap | $28.11M |
| P/E Ratio | -1.99 |
| EPS | $-0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.15 |
| 52-Week Low | $0.59 |
| Volume | 53.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.06M |
| Gross Margin | 0.00% |
ESLA analyst coverage data. Average price target: $0.00.